MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$418,761K
Net Income
$4,482K
Net Profit Margin
1.07%
EPS
$0.06
Unit: Thousand (K) dollars
Revenue Breakdown
US
Asia Pacific
Europe
Rest Of The World
Revenue Breakdown
Neurosurgery
Wound Reconstruction Solutions
Surgical Instruments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
418,761
391,918
434,925
402,062
Cost of goods sold
199,017
174,936
214,060
195,071
Research and development
24,253
23,501
24,790
22,456
Selling, general and administrative
172,436
178,235
169,267
169,046
Intangible asset amortization
3,770
3,776
3,768
3,728
Goodwill impairment charge
0
-
0
0
Total costs and expenses
399,476
380,448
411,885
390,301
Operating income (gain)
19,285
11,470
23,040
11,761
Interest income
4,267
4,106
4,362
4,982
Interest expense
22,994
22,465
23,673
22,725
Other income (expense), net
4,186
4,480
581
-842
Income (gain) before income taxes
4,744
-2,409
4,310
-6,824
Provision (benefit) for income taxes
262
2,208
6,014
-1,420
Net income (loss)
4,482
-4,617
-1,704
-5,404
Basic EPS
0.06
-0.06
-0.022
-0.07
Diluted EPS
0.06
-0.06
-0.022
-0.07
Basic Average Shares
77,293,000
76,951,000
76,777,000
76,753,000
Diluted Average Shares
78,168,000
76,951,000
76,777,000
76,753,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
US
$307,099K
(0.26%↑ Y/Y)
Asia Pacific
$48,697K
Europe
$42,572K
(-0.05%↓ Y/Y)
Rest Of The World
$20,393K
(7.50%↑ Y/Y)
Total revenue, net
$418,761K
(0.76%↑ Y/Y)
Operating income (gain)
$19,285K
(103.76%↑ Y/Y)
Interest income
$4,267K
(-9.41%↓ Y/Y)
Other income
(expense), net
$4,186K
(315.11%↑ Y/Y)
Total costs and
expenses
$399,476K
(-56.97%↓ Y/Y)
Income (gain) before
income taxes
$4,744K
(100.89%↑ Y/Y)
Interest expense
$22,994K
(9.28%↑ Y/Y)
Cost of goods sold
$199,017K
(-3.52%↓ Y/Y)
Selling, general and
administrative
$172,436K
(-4.14%↓ Y/Y)
Research and development
$24,253K
(-10.16%↓ Y/Y)
Intangible asset
amortization
$3,770K
(0.43%↑ Y/Y)
Net income (loss)
$4,482K
(100.93%↑ Y/Y)
Provision (benefit) for
income taxes
$262K
(100.56%↑ Y/Y)
Buy us a coffee
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)